Pretargeted alpha therapy in MUC16-positive high-grade serous ovarian cancer
{{output}}
Background: Peritoneal metastasis with micrometastatic cell clusters is a common feature of advanced ovarian cancer. Targeted alpha therapy (TAT) is an attractive approach for treating micrometastatic diseases as alpha particles ... ...